These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 25821809)
21. Inflammation as a Therapeutic Target for Diabetic Neuropathies. Pop-Busui R; Ang L; Holmes C; Gallagher K; Feldman EL Curr Diab Rep; 2016 Mar; 16(3):29. PubMed ID: 26897744 [TBL] [Abstract][Full Text] [Related]
22. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Kumar A; Kaundal RK; Iyer S; Sharma SS Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084 [TBL] [Abstract][Full Text] [Related]
23. Heme oxygenase-1, a novel target for the treatment of diabetic complications: focus on diabetic peripheral neuropathy. Negi G; Nakkina V; Kamble P; Sharma SS Pharmacol Res; 2015 Dec; 102():158-67. PubMed ID: 26432957 [TBL] [Abstract][Full Text] [Related]
24. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Ziegler D Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113 [TBL] [Abstract][Full Text] [Related]
25. NADPH oxidase: A membrane-bound enzyme and its inhibitors in diabetic complications. Laddha AP; Kulkarni YA Eur J Pharmacol; 2020 Aug; 881():173206. PubMed ID: 32442539 [TBL] [Abstract][Full Text] [Related]
26. Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats. Tian R; Yang W; Xue Q; Gao L; Huo J; Ren D; Chen X Eur J Pharmacol; 2016 Jan; 771():84-92. PubMed ID: 26688570 [TBL] [Abstract][Full Text] [Related]
27. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade. Tiwari V; Kuhad A; Chopra K Phytother Res; 2011 Oct; 25(10):1527-36. PubMed ID: 21394805 [TBL] [Abstract][Full Text] [Related]
28. D3T acts as a pro-oxidant in a cell culture model of diabetes-induced peripheral neuropathy. Stochelski MA; Wilmanski T; Walters M; Burgess JR Redox Biol; 2019 Feb; 21():101078. PubMed ID: 30593978 [TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of ferulic acid alone and in combination with insulin in streptozotocin induced diabetic neuropathy in Sprague Dawley rats. Dhaliwal J; Dhaliwal N; Akhtar A; Kuhad A; Chopra K Life Sci; 2020 Aug; 255():117856. PubMed ID: 32473246 [TBL] [Abstract][Full Text] [Related]
30. Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord. Zhao WC; Zhang B; Liao MJ; Zhang WX; He WY; Wang HB; Yang CX Neurosci Lett; 2014 Feb; 560():81-5. PubMed ID: 24370596 [TBL] [Abstract][Full Text] [Related]
31. Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy. Al-Rejaie SS; Aleisa AM; Abuohashish HM; Parmar MY; Ola MS; Al-Hosaini AA; Ahmed MM Neurol Res; 2015 Oct; 37(10):924-33. PubMed ID: 26187552 [TBL] [Abstract][Full Text] [Related]
32. Molecular Insights of Plant Phytochemicals Against Diabetic Neuropathy. Balkrishna A; Pathak R; Bhatt S; Arya V Curr Diabetes Rev; 2023; 19(9):e250822207994. PubMed ID: 36028963 [TBL] [Abstract][Full Text] [Related]
33. The antioxidant response as a drug target in diabetic neuropathy. Vincent AM; Edwards JL; Sadidi M; Feldman EL Curr Drug Targets; 2008 Jan; 9(1):94-100. PubMed ID: 18220717 [TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Dewanjee S; Das S; Das AK; Bhattacharjee N; Dihingia A; Dua TK; Kalita J; Manna P Eur J Pharmacol; 2018 Aug; 833():472-523. PubMed ID: 29966615 [TBL] [Abstract][Full Text] [Related]
35. Effect of Kaempferol isolated from seeds of Eruca sativa on changes of pain sensitivity in Streptozotocin-induced diabetic neuropathy. Kishore L; Kaur N; Singh R Inflammopharmacology; 2018 Aug; 26(4):993-1003. PubMed ID: 29159712 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of α-lipoic acid in diabetic neuropathy. Papanas N; Ziegler D Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809 [TBL] [Abstract][Full Text] [Related]
37. Role of Oxidative Stress and Inflammatory Factors in Diabetic Kidney Disease. Aghadavod E; Khodadadi S; Baradaran A; Nasri P; Bahmani M; Rafieian-Kopaei M Iran J Kidney Dis; 2016 Nov; 10(6):337-343. PubMed ID: 27903991 [TBL] [Abstract][Full Text] [Related]
38. Diabetic neuropathy and oxidative stress. Pop-Busui R; Sima A; Stevens M Diabetes Metab Res Rev; 2006; 22(4):257-73. PubMed ID: 16506271 [TBL] [Abstract][Full Text] [Related]
39. Hydrogen exerts neuroprotective effects by inhibiting oxidative stress in experimental diabetic peripheral neuropathy rats. Han XC; Ye ZH; Hu HJ; Sun Q; Fan DF Med Gas Res; 2023; 13(2):72-77. PubMed ID: 36204786 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Figueroa-Romero C; Sadidi M; Feldman EL Rev Endocr Metab Disord; 2008 Dec; 9(4):301-14. PubMed ID: 18709457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]